Guidelines and Resources
This website contains general information about medical conditions and treatments. The information is not advice, and should not be treated as such.
Guidelines committee welcomes comments and these can be sent to Dr. Michal Inbar-Feigenberg, chair of the guidelines committee at michal.inbar-feigenberg@sickkids.ca
Table of Contents
Table of Contents
Amino Acid- and Organic Acid Metabolism
Amino Acid- and Organic Acid Metabolism

Glutaric Aciduria
Glutaric Aciduria

Tyrosinemia Type 1 Recommendations
Tyrosinemia Type 1 Recommendations

Methylmalonic aciduria/propionic aciduria
Methylmalonic aciduria/propionic aciduria

MMA/PA suppplimentation
MMA/PA suppplimentation
Links for PKU Guidelines
Links for PKU Guidelines
NIH PKU conference and Agency for healthcare research and quality
Carbohydrate Metabolism
Carbohydrate Metabolism
Lysosomal Storage Disorders
Lysosomal Storage Disorders

Pompe Disease Guidelines
Pompe Disease Guidelines

MPS II – Consensus Position Statement
MPS II – Consensus Position Statement

Niemann Pick C
Niemann Pick C

Elosulfase alfa in the management of Morquio A Syndrome
Elosulfase alfa in the management of Morquio A Syndrome
Fabry Disease
Fabry Disease

Enzyme Replacement Treatment Eligibility Form
Enzyme Replacement Treatment Eligibility Form

Treatment Guidelines
Treatment Guidelines
Gaucher Disease
Gaucher Disease

Guidelines for Gaucher Disease
Guidelines for Gaucher Disease
ONTARIO GUIDELINES FOR TREATMENT OF GAUCHER DISEASE BY ENZYME REPLACEMENT WITH IMIGLUCERASE OR VELAGLUCERASE, OR SUBSTRATE REDUCTION THERAPY WITH MIGLUSTAT (Version 9; August 2011)
Congenital Disorders of Glycosylation
Congenital Disorders of Glycosylation

International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG)
International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG)
Other
Other
Hypophophatasia
Hypophophatasia

D-tagatase, Hereditary Fructose Intolerance and Health Canada approval
D-tagatase, Hereditary Fructose Intolerance and Health Canada approval

Terms of Reference for the National Canadian HPP Clinical Expert Committee
Terms of Reference for the National Canadian HPP Clinical Expert Committee

Prescribing Criteria
Overview
Prescribing Criteria
Overview

HPP ERT
Application Form
HPP ERT
Application Form

HPP Neonatal
Guidelines
HPP Neonatal
Guidelines

HPP Treatment
References
HPP Treatment
References
Evaluation and endorsement of existing guidelines using the AGREE II tool
Evaluation and endorsement of existing guidelines using the AGREE II tool

Diagnosis and treatment of tyrosinemia type I
Diagnosis and treatment of tyrosinemia type I

Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia
Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia

Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I
Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I

Pompe Disease, Summary of Guidelines Review, Dec. 2022
Pompe Disease, Summary of Guidelines Review, Dec. 2022

AGREE-Reporting-Checklist-2016
AGREE-Reporting-Checklist-2016